Harvard Bioscience Inc (NASDAQ:HBIO) reported Q1 revenue of $20.8 million, aligning with their expectations. Adjusted gross margin improved to 59%, a growth of nearly 300 basis points year-over-year.

A live webcast of the Sidoti fireside chat will be made available on Harvard Bioscience's Investor Relations website. An archived replay of the webcast will be available following the event. Harvard ...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a good company can see its share price rise well over 100%. For example, the Harvard ...

Shareholders will be ecstatic, with their stake up 51% over the past week following Harvard Bioscience, Inc.'s (NASDAQ:HBIO) latest full-year results. The results were mixed overall, with revenues ...

Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference ...

Image source: The Motley Fool. Harvard Bioscience (NASDAQ:HBIO) reported results highlighted by stable overall financials, year-over-year gross margin gains, and growing momentum from new product ...

Visit a quote page and your recently viewed tickers will be displayed here. Presently, Thomas W. Loewald holds the position of Chief Executive Officer & Director at Cambrex Corp. Mr. Loewald is also ...

As investors, we look for growing companies that can produce returns. Having said that, Harvard Bioscience stock looks ready for a run following yet another earnings beat. Will HBIO stock continue to ...